Thursday, May 19, 2022 5:27:58 PM
Today they announced new contracts including clinical trials of more than 1000 patients. This adds another facet the company can tap to maximize growth and shareholder value as they grow in the future.
Company has a significant short holding due to a demonstrably false short report put out by White Diamond Research. It did cause the company to shed about 1/3 of its value but if this is new to you that means you can get in now at a steep discount to most of the people who bought in over the last 12 months.
I am not an advisor, do your DD. I have personal shares. I am not associated with the company in any way. GL.
Recent RQHTF News
- Another Day, Another Healthcare Stock Finding Success • AllPennyStocks.com • 12/13/2023 06:40:00 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM